Clay Siegal: The Backbone of Seattle Genetics

Seattle Genetics has been manipulating, studying, and packaging drugs since it was established in the year 1998. They have been dedicated to study human antibodies and make responsive discoveries and innovations. Seattle Genetics has over 900 employees and a market value of around $10 billion and it takes pride in being the biggest biotechnology firm